Back to search
FDAFDA · Food and drugs·Recall number D-1595-2020

Red-E Tablet, Proprietary Blend 3000 mg**, packaged in 1-count plastic bag stapled with cardboard labeling.

Published September 30, 2020 · Recall initiated: September 1, 2020

Summary

FDA records drug Class I recall D-1595-2020, published September 30, 2020 and initiated September 1, 2020. Recalling firm: The Protein Shoppe; Status: Terminated; Reported quantity: 21,511 tablets; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
The Protein Shoppe
Distributor
Nationwide in the USA
Lot
All lots.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Red-E Tablet, Proprietary Blend 3000 mg**, packaged in 1-count plastic bag stapled with cardboard labeling. recalled?

Yes. FDA published recall D-1595-2020 on September 30, 2020. Reported hazard: Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release